Doctor profile · Federal record
Dr. Claudia Fish, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Endocrinology, Diabetes & Metabolism Physician · Park City, UT
- NPI 1043293665
- Accepts Medicare
- 34 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
900 Round Valley Dr Ste 200
Park City, UT 840607552
(435) 658-7400
fax (435) 658-7424 - Mailing address
-
Po Box 27128
Salt Lake City, UT 841270128
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- January 8, 2026
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Utah #14188825-8905 · New York #206675
- Medicaid
- NY #01763560
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043293665. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
24,099
Distinct HCPCS
10
Medicare allowed
$482,515
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 13,650 | 19 | $9 | |
J0897 |
Injection, denosumab, 1 mg | 7,500 | 85 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 885 | 526 | $123 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 495 | 286 | $3 | |
83036 |
Hemoglobin a1c level | 495 | 286 | $9 | |
96372 |
Injection of drug or substance under skin or into muscle | 228 | 111 | $13 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 193 | 95 | $33 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 167 | 142 | $87 | |
J3489 |
Injection, zoledronic acid, 1 mg | 156 | 31 | $8 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 73 | 73 | $214 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,338. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$83,814
Transactions
170
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 157 | $83,389.04 | |
| ABBVIE INC. | 3 | $165.59 | |
| Amgen Inc. | 3 | $70.76 | |
| Insulet Corporation | 2 | $69.44 | |
| Madrigal Pharmaceuticals | 1 | $41.77 | |
| Chiesi USA, Inc. | 1 | $20.68 | |
| Abbott Laboratories | 1 | $20.26 | |
| AstraZeneca Pharmaceuticals LP | 1 | $20.01 | |
| PFIZER INC. | 1 | $16.65 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,784
Patients
597
Total drug cost
$1,568,408
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 288 | 86 | $5,787 |
| Trulicity (Dulaglutide) | Brand | 265 | 84 | $526,263 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 236 | 86 | $4,843 |
| Jardiance (Empagliflozin) | Brand | 184 | 60 | $258,552 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 126 | 47 | $183,508 |
| Ozempic (Semaglutide) | Brand | 86 | 29 | $174,043 |
| Methimazole | Generic | 83 | 27 | $1,131 |
| Novolog Flexpen (Insulin Aspart) | Brand | 83 | 31 | $80,808 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 77 | 31 | $52,641 |
| Metformin Hcl | Generic | 75 | 24 | $760 |
Frequently asked questions
What is Dr. Claudia Fish's medical specialty?
Dr. Claudia Fish practices Endocrinology, Diabetes & Metabolism Physician in Park City, UT.
Where does Dr. Claudia Fish practice?
Dr. Claudia Fish practices at 900 Round Valley Dr Ste 200, Park City, UT 840607552. Office phone: 4356587400.
What is Dr. Claudia Fish's NPI?
Dr. Claudia Fish's National Provider Identifier (NPI) is 1043293665, issued by NPPES.
Does Dr. Claudia Fish accept Medicare assignment?
Yes. Dr. Claudia Fish accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Claudia Fish commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.